Effect of Cardiovascular Autonomic Neuropathy on AKI and Outcomes in Isolated CABG Surgery
NCT07254468
Acute Kidney Injury, Acute Kidney Injury (AKI)
Antalya, Turkey (Türkiye)
View Trial DetailsNCT Number: NCT04165369
The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials.
The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Mansoura University Hospitals, Al Mansurah, Egypt
Acute kidney injury (AKI) is a severe clinical complication with increasing incidence and is associated with adverse short- and long-term outcomes resulting in a major health care burden worldwide. The introduction of consensus classification systems has enhanced the awareness for AKI. The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials. However, analyzing AKI from existing databases is often limited by missing data elements, especially the inclusion of the urine output criteria. Missing data and the use of different definitions before the consensus classification are the reasons for large variations in reported occurrences of surgical induced AKI.
The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit (e.g., Intensive Care Unit, Intermediate Care, Post Anesthesia Care Unit) using the latest consensus definition for AKI (Kidney Disease: Improving Global Outcomes criteria) and a standardized data collection instrument and to assess the dependence of AKI on preoperative and intraoperative factors.
Method: International prospective, observational, multi-center, cross-sectional cohort study
Eligible patients will be identified during preoperative assessment. All eligible patients will be approached to obtain written consent.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 72 hours after extended surgery
Occurrence of acute kidney injury according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria
Time frame: 72 hours after extended surgery
Definition and classification of acute injury according to the KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guidelines on acute kidney injury
Time frame: up to 90 days after extended surgery
Time frame: up to 90 days after extended surgery
Time frame: up to 90 days after extended surgery (until discharge)
Time frame: up to 90 days after extended surgery (until discharge)
Time frame: up to 90 days after extended surgery
combined endpoint consisting of mortality, renal replacement therapy, persistent renal dysfunction defined as serum-creatinine >= 1.5 times as compared to baseline serum-creatinine
University Hospital Muenster
Other
Acronym: Epis-AKI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07254468
Acute Kidney Injury, Acute Kidney Injury (AKI)
Antalya, Turkey (Türkiye)
View Trial DetailsNCT06633029
Acute Kidney Injury, Acute Kidney Injury (AKI)
Birmingham, Alabama, United States
View Trial DetailsNCT07025941
Acute Kidney Injury, Acute Kidney Injury (AKI)
Taizhou, Jiangsu, China
View Trial DetailsNCT02733328
Acute Kidney Injury, Acute Kidney Injury (AKI)
Wolverhampton, West Midlands, United Kingdom
View Trial Details